Joseph E. Payne - 17 Dec 2025 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role
President and CEO, Director
Signature
/s/ Ilan Katz, attorney-in-fact
Issuer symbol
ARCT
Transactions as of
17 Dec 2025
Net transactions value
$0
Form type
4
Filing time
19 Dec 2025, 17:21:26 UTC
Previous filing
18 Dec 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Payne Joseph E President and CEO, Director C/O ARCTURUS THERAPEUTICS HOLDINGS INC., 10285 SCIENCE CENTER DRIVE, SAN DIEGO /s/ Ilan Katz, attorney-in-fact 19 Dec 2025 0001727315

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARCT Employee Stock Option (right to buy) Award $0 +175,000 $0.000000 175,000 17 Dec 2025 Common Stock 175,000 $6.52 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended.
F2 The shares underlying this option vest 25% on December 17, 2026, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months.